Atlas Trials

Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma

Clinical trial NCT02959164 · COMPLETED

Trial details

NCT number
NCT02959164
Sponsor
Mohammed Milhem
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Ductal AdenocarcinomaSarcoma
Start date
2016-12-05
Primary completion
2019-09-30
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.